Financhill
Back

Rocket Companies Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

RKT
Rocket Companies

Last Price:
14.36
Seasonality Move:
3.45%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
137.07
Seasonality Move:
14.88%
Sell
34
Rocket Companies (RKT) is a Sell

Is Rocket Companies a Buy, Sell or Hold?

  • The current Rocket Companies [RKT] share price is $14.06. The Score for RKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • RKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RKT Stock Price Chart

What is Rocket Companies's stock price today?

  • The Rocket Companies share price today is $14.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RKT is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.86 Sell
Relative Strength Index (14 RSI): 37.11 Sell
Chaikin Money Flow: -45973 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.03 - 16.35) Sell
Bollinger Bands (100): (15.02 - 19.3) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

RKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.8 Buy
20-day SMA: 14.88 Sell
50-day SMA: 16.82 Sell
200-day SMA: 15.17 Sell
8-day EMA: 14.1 Sell
20-day EMA: 14.81 Sell
50-day EMA: 16.07 Sell
200-day EMA: 15.26 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Rocket Companies Earnings Growth & RKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.39 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Rocket Companies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):